Výsledky vyhledávání - "González-Hernández G"

Akademický článek

Nitrous oxide induces hypothermia and TrkB activation: Maintenance of body temperature abolishes antidepressant-like effects in mice.

Autor: Alitalo O; Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Finland; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Finland., Kohtala S; Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Finland; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Finland., Rosenholm M; Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Finland; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Finland; Center for Translational Neuromedicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark., Saarreharju R; Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Finland; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Finland., González-Hernández G; Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Finland; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Finland; Neuropsychopharmacology and Psychobiology Research Group, Department of Neurosciences, University of Cádiz, Cádiz, Spain., Sarparanta M; Department of Chemistry, University of Helsinki, Finland., Rozov S; Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Finland; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Finland., Rantamäki T; Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Finland; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Finland. Electronic address: tomi.rantamaki@helsinki.fi.

Publikováno v: Neuropharmacology [Neuropharmacology] 2024 Dec 15; Vol. 261, pp. 110172. Date of Electronic Publication: 2024 Oct 02.

Zobrazit plný text záznamu

Akademický článek

Linking Hypothermia and Altered Metabolism with TrkB Activation.

Autor: Alitalo O; Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland.; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland., González-Hernández G; Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland.; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland., Rosenholm M; Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland.; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland.; Center for Translational Neuromedicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen DK-2200, Denmark., Kohtala P; Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland.; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland.; Department of Psychiatry, Weill Cornell Medicine, New York, New York 10021, United States., Matsui N; Faculty of Pharmacy, Gifu University of Medical Science, 4-3-3 Nijigaoka, Kani, Gifu 509-0293, Japan., Müller HK; Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus N 8200, Denmark., Theilmann W; Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland., Klein A; Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen DK-2200, Denmark.; Department of Drug Design & Pharmacology, University of Copenhagen, Copenhagen DK-2100, Denmark., Kärkkäinen O; School of Pharmacy, University of Eastern Finland, Kuopio 70210, Finland.; Afekta Technologies Ltd., Kuopio 70210, Finland., Rozov S; Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland.; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland., Rantamäki T; Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland.; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland., Kohtala S; Laboratory of Neurotherapeutics, Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland.; SleepWell Research Program, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland.; Department of Psychiatry, Weill Cornell Medicine, New York, New York 10021, United States.

Publikováno v: ACS chemical neuroscience [ACS Chem Neurosci] 2023 Sep 06; Vol. 14 (17), pp. 3212-3225. Date of Electronic Publication: 2023 Aug 08.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání